| Specialty: |
Cardiology, Interventional Cardiology, Endovascular Diseases |
| Post Doctoral Training: |
- Fellow in Interventional Cardiology
The Division of Cardiology
The New York Hospital – Cornell University Medical Center
New York, New York
July 1997 – June 1998
- Fellow in Cardiology
The New York Hospital – Cornell University Medical Center
New York, New York
July 1994 – June 1997
- Intern/Resident in Internal Medicine
Department of Medicine
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania
July 1991 – June 1994
|
| Education: |
- Albany Medical College
Albany, New York
MD, May 1991
- The Johns Hopkins University
Baltimore, Maryland
BA, Natural Science, May 1987
|
| Academic Appointments: |
Instructor in Medicine
Department of Medicine
The New York Hospital – Cornell University Medical Center
June 1996 – June 1998 |
| Current Hospital Appointments: |
- Los Alamitos Medical Center
3751 Katella Avenue
Los Alamitos, California 90720
- Long Beach Memorial Medical Center
2801 Atlantic Avenue
Long Beach, California 90801
- Lakewood Regional Medical Center
3700 South Street
Lakewood, California 90712
|
Committees/
Appointments |
- Chairman of Department of Medicine
Los Alamitos Medical Center, January 2007 – present
- Chairman of Allied Health Committee
Los Alamitos Medical Center, January 2006 – December 2006
- Member, Medical Executive Committee
Los Alamitos Medical Center, January 2006 – present
- Member, Myocardial Infarction Quality Assurance Committee
Los Alamitos Medical Center, January 2001 – present
- Member, Cardiovascular Quality Assurance Committee
Long Beach Memorial Medical Center, January 2000 – present
|
| Previous Hospital Appointments: |
- General Hospital of Passaic
350 Boulevard
Passaic, New Jersey 07055
July 1998 – August 1999
- Saint Mary’s Hospital
211 Pennington Avenue
Passaic, New Jersey 07055
July 1998 – August 1999
- Saint Joseph’s Hospital and Medical Center
703 Main Street
Passaic, New Jersey 07055
July 1998 – August 1999
- Chilton Memorial Hospital
97 West Parkway
Pomptom Plains, New Jersey 07444
July 1998 – August 1999
- Passaic Beth Israel Hospital
70 Parker Avenue
Passaic, New Jersey 07055
July 1998 – August 1999
|
| Prior Employment: |
- Cardiology Associates of North Jersey
1030 Clifton Avenue
Clifton, New Jersey 07013
July 1998 – August 1999
- Urgent Care Physician
Memorial Sloan Kettering Cancer Center
New York, New York
July 1994 – June 1996
|
| Board
Certifications: |
- American Board of Internal Medicine
Certified in Internal Medicine
1994 (Recertification 2004)
- American Board of Internal Medicine
Certified in Cardiovascular Disease
1997 (Recertification 2004)
- American Board of Internal Medicine
Certified in Interventional Cardiology
1999
(Recertification 2009)
|
| Professional Societies: |
- American College of Cardiology, Fellow (FACC)
- American College of Physician, Member
- Society of Cardiovascular CT, Member
- Los Angeles County Medical Association, Member
- American Medical Association, Member
|
| Publications: |
- Novel distal occluder washout methods for prevention of no-reflow during stenting of saphenous vein grafts. Shaknovich A, Forman ST, Parikh M, Deutsch E, Bergman G, McCaffery T, Newman GC, Tarazona N and Sanborn T.
Catheter Cardiovascular Intervention 1999 Aug: 47(4): 397 – 403.
- Adenosine radionuclide perfusion imaging in the preoperative evaluation of patients undergoing peripheral vascular Surgery Marshall ES, Raichlen JS, Forman S, Heyrich GP, Keen WD, Weitz HH. American Journal of Cardiology 1995 Oct 15: 76(11):817 – 821.
|
| Additional Research Experience: |
- Systolic and diastolic myocardial dysfunction during endotoxemia in pigs. Proctor: Roy D Goldfarb, Phd
Department of Physiology, Albany Medical College, 1989 - 1991
- A Phase III, double-blind, randomized placebo-controlled study, to evaluate the effects of dalcetrapib on cardiovascular (CV) risk in stable CHD patients, with a documented recent Acute Coronary Syndrome (ACS).
Sponsor: F.Hoffmann-La Roche Ltd. Hoffmann-La Roche, Inc. Roche Global Development
- A Multi-center, Randomized, Controlled Study to Investigate the Safety and Tolerability of Intravenous Ferric Carboxymaltose (FCM) vs. Iron Dextran in treating Iron Deficiency Anemia in Subjects Who Are Not Dialysis Dependent.
Sponsor: Luitpold Pharmaceuticals, Inc.
- A Phase3, randomized, Double-Blind, Double-Dummy, Parallel Group, Multi-Center, Multi-National Study for Evaluation of Efficacy and Safety of DU-176B Versus Warfarin in Subjects with Atrial Fibrillation - Effective aNticoaGulation with xA next Generation in Aterial Fibrillation. (ENGAGE-AF).
Sponsor: Daiichi Sankyo Pharma Development
- Freedom - A Frequent Optimization Study the Quick Opt ™ Method.
St Jude
- Registry of AT/AF Episodes in the CRM Device Population: Rate Registry.
St. Jude
- PA 32540-302: A 6-Month, Phase 3, Randomized, Double-Blind, Parallel-Group, Controlled, Multi-Center Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers.
|